Sanofi India Chief Departs, Sets Transformative Path

Outgoing Exec To Lead SeQuent Scientific

Sanofi India's managing director is moving on after an eventful innings that saw the company re-orient operations, moving out of certain non-strategic areas to focus on core therapies. Pre-pandemic early digital adoption appears to have played out well too for the French group’s listed Indian arm.

leadership
Leadership Change At Sanofi India • Source: Alamy

Sanofi India Ltd. managing director Rajaram Narayanan is moving on after four action-packed years at the helm, which have seen the French group’s Indian arm emerge leaner, focused more sharply on its core portfolio and perhaps more “future-equipped”, backed by well-entrenched digital capabilities. The executive is headed to India's largest animal healthcare company SeQuent Scientific Limited as managing director and CEO.

Rajaram, who joined Sanofi India in 2014 and took over as managing director in 2018, is known to have a...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Business

More from Scrip

Merck & Co. Remains In The BD Game After Verona Takeout

 

CEO Rob Davis said the company is in pursuit of more deals as it looks to close the revenue gap looming from the loss of Keytruda in 2028.

Asia Deal Watch: JXR And Alexion Build Upon Existing Gene Therapy Alliances

Plus deals involving TandemAI/Perpetual Medicines, Biocytogen/BeOne, Chugai/Gero, CStone/Istituto Gentili, Alembic/Utility, Brii/Joincare, HanchorBio/Henlius, Rakuten/Cyntec and more.

Ultragenyx and Mereo Still Confident Despite Setrusumab Slip Up

 
• By 

The osteogenesis imperfecta drug stumbled in a second interim analysis.